-
- Posted Thursday March 3, 2016
Cycle for the Cure offers more locations and activities supporting TGen cancer research
Organizers add Chandler and Phoenix health clubs in May 1 quest to raise a record $200,000
PHOENIX, Ariz. - March 3, 2016 - The 6th annual
Cycle for the Cure on May 1 - one of the most exciting
ways to support cancer research at theTranslational
Genomics Research Institute (TGen) - is bigger than ever for
2016.
Slots are quickly selling out for the 2-hour, heart-pumping indoor
cycling events, hosted by the all four Village Health Clubs and
Studio 360. Cycle for the Cure organizers hope to raise a
record $200,000 this year, eclipsing the $182,000 raised for TGen
cancer research in 2015.
Riding slots require a minimum $200 tax-deductible donation, and
riders are encouraged to raise additional research funds.
Two locations have been added this year:
• The recently opened Ocotillo Village Health
Club & Spa, 4200 S. Alma School Road, Chandler; 8-10 a.m.
• Studio 360, 3627 E. Indian School Road, #102,
Phoenix; 12-2 p.m.
Returning sites are:
• Gainey Village Health Club & Spa, 7477 E.
Doubletree Ranch Road, Scottsdale; 8-10 a.m.
• DC Ranch Village Health Club & Spa, 18501
N. Thompson Peak Parkway, Scottsdale; 10 a.m.-12 p.m.
• Camelback Village Racquet & Health Club,
4444 E. Camelback Road, Phoenix; 3-5 p.m.
In addition, Cycle for the Cure this year includes yoga
classes for $50 donations:
• DC Ranch, 90-minute hot yoga; 10 a.m.
• Camelback Village, 90-minute yoga; 3:30
p.m.
All locations welcome non-members to participate in Cycle for
the Cure. Registration starts today, March 3, at www.tgenfoundation.org/cycle.
Corporate sponsorships are available: Platinum, $7,500 and higher;
Gold, $5,000; Silver, $2,500; and Bronze, $1,000.
A post-ride party for all participants from all the clubs will be
hosted at Camelback Village at 5 p.m., following the last ride. It
will feature a return musical performance by Nate Nathan and
MacDaddy-o's band, which was a huge hit last year. The party is
free for riders; $20 donation for guests.
Using genomic sequencing, TGen helps doctors match the appropriate
therapy to each patient's DNA profile, producing the greatest
patient benefit. This year, Cycle for the Cure is focused
on raising research funds for work on a revolutionary diagnostic
method called "liquid biopsies" - biomarkers in circulating blood -
as a means of providing patients and their doctors with early
detection of disease.
Dr. Jeffrey Trent, TGen President and Research Director, will be
among TGen's renowned scientists participating in Cycle for the
Cure.
"Funds raised by Cycle for the Cure remain in Arizona
for TGen research. Local research means local patients benefit
first," said Robyn DeBell, one of the event's co-chairs. "Being
involved in TGen is like having a sneak peak at the future of
medicine."
"Cycle for the Cure is getting bigger and more exciting
every year," said Vicki Vaughn, the event's other co-chair. "In
supporting this event, the public not only supports TGen, but also
supports the economic impact - now at $174 million annually - that
TGen provides Arizona."
"TGen is so very fortunate to have collaborative partners like the
Village Health Clubs and to the dynamic volunteers like Robyn
DeBell and Vicki Vaughn who work tirelessly to advance TGen's
research," said TGen Foundation President Michael Bassoff.
"Cycle for the Curehelps us provide hope and answers
for cancer patients and their families who need our help
today."
# # #
About TGen
Translational Genomics Research Institute (TGen) is a Phoenix,
Arizona-based non-profit organization dedicated to conducting
groundbreaking research with life changing results. TGen is focused
on helping patients with neurological disorders, cancer, and
diabetes, through cutting edge translational research (the process
of rapidly moving research towards patient benefit). TGen
physicians and scientists work to unravel the genetic components of
both common and rare complex diseases in adults and children.
Working with collaborators in the scientific and medical
communities literally worldwide, TGen makes a substantial
contribution to help our patients through efficiency and
effectiveness of the translational process. For more information,
visit:www.tgen.org. Follow TGen onFacebook,LinkedInandTwitter @TGen.
Press Contacts:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
[email protected]
